The Europe Flexible Endoscopes Market was valued at $682.1 Million in 2025 and projected to reach to $841.8 Million by 2030, representing a compound annual growth rate of 4.3%. Europe's flexible endoscopes market demonstrates resilience with steady growth driven by aging populations, increasing prevalence of gastrointestinal and respiratory disorders, and widespread adoption of minimally invasive procedures.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's well-established healthcare systems and high adoption rates of minimally invasive procedures create a stable foundation for flexible endoscope demand across gastroenterology, pulmonology, and ENT specialties.
Germany dominates Europe's flexible endoscopes market with $43.5 million in market size, driven by advanced medical technology adoption and strong reimbursement policies supporting endoscopic procedures.
Europe's flexible endoscopes market is projected to grow from $682.1 million in 2025 to $841.8 million by 2030 at a 4.3% CAGR, reflecting consistent demand for diagnostic and therapeutic endoscopy.
Stringent CE marking requirements and ISO compliance standards in Europe ensure high-quality device manufacturing, supporting premium pricing and sustained market confidence among healthcare providers.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ENT ENDOSCOPY (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.1% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 2.39 (2025) |
| Revenue Forecast (Billions) | ~USD 3.07 (2030) |
| Segments Covered | Type, Application, End User |
3 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ASCS | 32.4 | 33.6 | 35.3 | 36.8 | 38.4 | 40.1 | 42.1 | 44.1 | 4.6 |
| CLINICS | 20.2 | 20.9 | 21.9 | 22.7 | 23.6 | 24.6 | 25.7 | 26.9 | 4.2 |
| HOSPITALS | 76.3 | 79 | 82.8 | 86.1 | 89.8 | 93.7 | 98 | 102.7 | 4.4 |
| OTHER END USERS | 30.2 | 30.7 | 31.7 | 32.4 | 33.3 | 34.2 | 35.2 | 36.2 | 2.7 |
| TOTAL | 159 | 164.2 | 171.6 | 178.1 | 185 | 192.6 | 201 | 210 | 4.1 |
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ASCS | 128.8 | 133.8 | 140.8 | 146.9 | 153.6 | 160.9 | 168.9 | 177.6 | 4.8 |
| CLINICS | 79.2 | 82 | 86 | 89.4 | 93.2 | 97.3 | 101.8 | 106.6 | 4.4 |
| HOSPITALS | 303.9 | 315.2 | 331 | 345 | 360.1 | 376.6 | 394.7 | 414.2 | 4.6 |
| OTHER END USERS | 118 | 120.4 | 124.4 | 127.5 | 130.9 | 134.7 | 138.9 | 143.4 | 2.9 |
| TOTAL | 629.9 | 651.3 | 682.1 | 708.9 | 737.8 | 769.5 | 804.3 | 841.8 | 4.3 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopy Systems,Advanced Energy Devices, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (Interventional Cardiology & Structural Heart),Cardiac Rhythm Management & Electrophysiology,MedSurg – Endoscopy (GI & Pulmonary), |
| FUJIFILM CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document services, graphic communications, inkjet),Electronics (display/touch panels, semiconductor materials, storage, industrial equipment, fine chemicals), |
| HOYA CORPORATION | Japan | Public Company | Ophthalmic lenses and eyeglasses,Contact lenses and Eyecity retail,Medical endoscopes, intraocular lenses, and surgical instruments, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related products,Injection, infusion, and hospital products,Pharmaceuticals (generic and kit products), |
| STERIS | Ireland | Public Company | Healthcare equipment (sterilizers, washers, OR infrastructure),Healthcare consumables and service contracts,Applied Sterilization Technologies (outsourced sterilization services), |
| HUGER MEDICAL INSTRUMENT CO., LTD | China | Private Company | Video endoscopy systems (towers, cameras, processors),Endoscopes and accessories,Light sources and visualization peripherals, |
| SONOSCAPE MEDICAL CORP. | China | Public Company | Human ultrasound (trolley and portable, B/W and color Doppler),Endoscopic diagnosis and treatment (GI, pulmonology, EUS, duodenoscopes, processors),Minimally invasive surgery camera systems and flexible endoscopes, |
Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer in imaging and medical technology sectors.
Boston Scientific Corporation is a United States public company founded in 1979 with 59,000 employees. The company develops and manufactures medical devices across multiple therapeutic areas.
Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. The company operates in imaging, information technology, and healthcare sectors.
Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products and medical devices.
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company produces medical devices and pharmaceutical products.
STERIS is a public company based in Ireland and founded in 1985. The company provides sterilization and contamination control solutions for healthcare and life sciences.
Huger Medical Instrument Co., Ltd. is a Chinese private company founded in 1984. The company manufactures medical instruments.
Sonoscape Medical Corp. is a Chinese public company founded in 2002 with 3,133 employees. The company develops and produces ultrasound imaging equipment.
| Country | 2025 size (native) |
|---|---|
| Germany | USD 43.5 Million |
| UK | USD 27.5 Million |
| France | USD 15.3 Million |
| Italy | USD 15.6 Million |
| Spain | USD 11.3 Million |
| Rest Of Europe | USD 37.6 Million |
Europe's flexible endoscopes market is valued at $682.1 million in 2025 and is expected to reach $841.8 million by 2030.
Europe's flexible endoscopes market is growing at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2030.
Key drivers include Europe's aging population, rising prevalence of gastrointestinal and respiratory disorders, advanced healthcare infrastructure, strong reimbursement frameworks, and increased investment in cancer screening programs.
Flexible endoscopes are primarily used in Europe across gastroenterology, pulmonology, and urology for diagnostic and therapeutic procedures.
Europe's stringent regulatory standards and emphasis on patient safety accelerate the adoption of advanced technologies such as high-definition and digital endoscopy systems.
The research study involved major activities in estimating the current size of the flexible endoscopes market. Exhaustive secondary research was done to collect information on the flexible endoscope industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the flexible endoscopes market.
The secondary research process involved the widespread use of secondary sources, directories, databases (Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources, such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS). These sources were referred to, to identify and collect information on the global flexible endoscopes market study. They were also used to obtain important information about the key players and market classification & segmentation according to industry trends and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts, such as CEOs, vice presidents; marketing and sales directors; technology & innovation directors; and related key executives from various key companies and organizations in the flexible endoscopes market. Primary sources from the demand side included ambulatory surgical centers (ASCs), hospitals, clinics, and other end users. The research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents involved in the research process is provided below:
C-level Primaries include CEOs, CFOs, COOs, and VPs.
Others include Sales Managers, Marketing Managers, Business Development Managers, Product Managers, Distributors, and Suppliers.
Companies are classified into tiers based on their total revenue. These tiers are as follows:
Tier 1 = > USD 10.00 billion, tier 2 = USD 1.00 billion to USD 10.00 billion, and tier 3 = < USD 1.00 billion
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For global market value, annual revenue figures were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global flexible endoscopes market. All major product manufacturers were identified at the international/country/regional levels. Revenue mapping for the respective business segments/sub-segments was done for the major players.
The global flexible endoscopes market was split into various segments and sub-segments by taking the following into consideration:

After arriving at the overall size of the global flexible endoscopes market through the methodology mentioned above, the market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Flexible endoscopes are medical devices designed with a bendable, tube-like structure that enables visual examination and therapeutic intervention within internal organs and cavities, particularly in hard-to-reach areas. These devices, integrated with high-resolution imaging, illumination, and accessory channels, support minimally invasive procedures across gastrointestinal, respiratory, urology, and other applications. Their flexibility, precision, and patient-friendly design make diagnostic accuracy and procedural efficiency essential in modern healthcare.
Full forecast, segment splits, and company analysis for all Flexible Endoscopes Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report